Background: Studies have shown that women are less likely to receive reperfusion therapy and have higher inhospital death in ST Elevation myocardial infarction(STEMI) as compared to men. This study aims to examine presentation, acute therapy, and inhopital mortality in women admitted with diagnosis of acute STEMI in a tertiary care cardiac center.
INTRODUCTION
Coronary artery disease is the leading cause of death in both men and women worldwide. 1 Number of studies has shown that there is gender difference in presentation, management and outcome in acute coronary syndrome. [2] [3] [4] [5] [6] Some studies have shown that females are less likely to receive reperfusion therapy in ST Elevation myocardial infarction(STEMI) as compared to males. 2, 3 Other studies report that women who present with acute myocardial infarction have worse in-hospital and long-term prognoses than men. [4] [5] [6] It is uncertain whether these differences reflect differences in base-line characteristics or pathophysiologic distinctions between men and women. 7 Part of the difference in mortality between gender is accounted for by the older age of and higher prevalence of comorbidities in women. 5 Less frequent use of revascularization procedures in women also may account for some of the excess mortality.
Findings from large database studies 6, [8] [9] [10] have indicated that women with acute myocardial infarction tend to undergo less aggressive hospital management than men. The aim of this study was to examine presentation, acute therapy, and inhopital mortality in women as compared to men admitted with diagnosis of acute STEMI in a tertiary care cardiac center. A total of 356 patients were enrolled in the study. More than two third of the patients were men (69% vs 31%). Mean age of women were about 6 years more than that of men (63 vs 56.9 yrs).Smoking and history of diabetes were more prevalent in women.
METHODS

All
Prehospital delay
Both men and women had long prehospital delay. Median duration of presentation to hospital after symptoms onset was 10 hours more in women. More than fifty percent of men presented within 12 hours of symptoms onset while only one third of women presented within 12 hours of symptom onset.
Management
Overall less than fifty percent of patients received reperfusion therapy. Reperfusion was similar in both men and women (men 46.4%, women 46.8%). Both groups received primary PCI equally (men 26.4%, women 27%). Among patients who presented within 12 hours, the rate of reperfusion therapy was similar in both groups.( Men 87%, women 90%).
Fig 1: Management of patients
Inhospital mortality
Overall inhospital death was 8.7%. Inhospital death was more than two times in women than in men(13.5% vs 6.5%, p value-0.02). Besides sex, nine other variables ( duration of presentation > 12hours, age>60 years, hypertension, diabetes, dyslipidemia, renal dysfunction, smoking, killip class at presentation>I and lack of reperfucion therapy) were assessed in univariate analysis with outcome as inhospital death. Women, DOP >12 hours, age >60 years and Killip It was similar to a registry in Germany, Heer T. found that men were predominant (70%) than women. 6 Men were also predominant in studies conducted in Nepal. In Kathmandu, men were 82%, 14 in Pokhara 51.7% 15 and in the Western Nepal ACS registry 62.3%. 16 Women were about 6 years older than men. This finding was also similar to other studies internationally and in Nepal. 4 , 6, [15] [16] [17] In accordance to other studies 4 , 6,17-18 diabetes was more common in women. But in study conducted in Pokhara, Parajuli M found that diabetes was more common in men (15% vs 10%). Overall smoking was highly prevalent(40%) in our study in both gender. It is similar to other studies where it varied from 55-80% . 4, [14] [15] [16] In contrast to other studies, 4, 15 smoking was more prevalent in women as compared to men (51% vs 35%, p value 0.03). This shows higher prevalence of smoking in women with STEMI and as this is one of the major risk facor for CAD, every effort should be applied so as to help quit smoking. Besides these, there were no significant difference in hypertension, dyslipidemia, renal dysfunction and Killip Class>1 at presentation between men and women. The median prehospital delay was 16 hours. Only half of the men and one third of the women presented within 12 hours of symptoms onset. This is quite high as compared to other studies. The median PHT is 3.5 hours in the USA and 2.5 hours in the United Kingdom, but 4.4 hours in South Korea and 4.5 hours in Japan 19 and in India 5.3 hours. 20 The median prehospital delay in our study was even more in women (22 hours vs 12 hours, p value 0.02). The outcome of treatment is directly dependent upon the early reperfusion therapy, longer prehospital delay have poorer outcome. 13 The cause of longer prehospital delay should be studied moreover in women so as to decrease prehospital delay and to achieve better outcome. With regard to reperfusion treatment, only 46.6% of the patients received reperfusion therapy overall. Women received reperfusion therapy equally to men in our study (46.8% vs 46.4%). Primary PCI(27% vs 26.4%)and thrombolysis(19.8% vs 20%) was also similar. This is in contrast to other studies where women were less likely than men to undergo intravenous thrombolysis and invasive cardiac reperfusion procedures. 6, 22 In MITRA registry 48.6% of women received reperfusion therapy as compared to 62.5% of men. 6 This study shows that women received reperfusion therapy equal to men. Consistent with most previous investigations, 6, [22] [23] women in our study had a higher risk for hospital death after STEMI than men(13.5% vs 6.5%, p value 0.02). The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries-I (GUSTO-I) angiographic study found gender to be an independent predictor of 30-day mortality after adjustment for clinical variables. 24 In the Myocardial Infarction Triage and Intervention Trial (MITI) registry, Kudenchuk PJ found that female gender independently predicted almost a doubling of hospital mortality. 25 After adjusting for age and in combination with other variables, including clinical risk factors and acute reperfusion strategies, we still found a gender difference in hospital mortality, with higher mortality rates in women.(p value -0.005). The cause of increased mortality in women can be attributed to older age, more comorbid conditions and delayed presentation to hospital.
LIMITATIONS
The data represents from only one center in Nepal, so its results cannot be generalized to rest of country. Many of the patients were referred from other hospitals which might be the reason for longer prehospital delay. Patients who expired in emergency room and who were not admitted were not included in the study.
CONCLUSION
More than two third of the patients were men. Women were likely to be diabetic and smokers. Women presented to hospital significantly later than men after symptom onset. Women received reperfusion therapy similar to that of men. Inhospital mortality was more in women. Women and Killip class at presentation >I were significant predictor of inhospital death after adjustment with other variables.
